z-logo
open-access-imgOpen Access
Acute Lymphoblastic Leukaemia: A Case Report of Long-term Disease-free Survival in a Resource Limited Setting
Author(s) -
ED Jatau,
DE Joseph,
JO Egesie,
OD Damulak,
TO Piwuna,
AM Onoja,
OJ Ewuga,
VT Ma'an,
Z Ayuba,
C N Okeke
Publication year - 2020
Publication title -
journal of biomedical research and clinical practice
Language(s) - English
Resource type - Journals
eISSN - 2651-5865
pISSN - 2636-7378
DOI - 10.46912/jbrcp.182
Subject(s) - medicine , vincristine , cyclophosphamide , bone marrow , prednisolone , pediatrics , surgery , chemotherapy
Acute Lymphoblastic Leukaemia (ALL) a malignant proliferation of immature lymphoid cells is a biologically heterogeneous disorder with variable outcomes in adults. We present a case report of a 54 year old woman who presented with fever, anaemia and peripheral lymphadenopathy of four weeks duration, and was managed for disseminated tuberculosis initially. Full blood count and bone marrow aspiration cytology constituted part of her initial investigations and were found to be in keeping with acute lymphoblastic leukaemia (ALL-L3). Patient had supportive treatment and managed with Cyclophosphamide, Vincristine (Oncovin), Cytosine Arabinoside and Prednisolone (COAP Regimen), achieved complete clinical and haematologic remission, and has remained disease free after consolidation and maintenance therapy. No evidence of haematologic or clinical relapse at five years and currently in her ninth-year post diagnosis and treatment. With high index of suspicion, timely investigation and referral, satisfactory outcomes are achievable in managing some patients with acute lymphoblastic leukaemia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom